Microbial targeting of 99mTc-labeled recombinant human β-defensin-3 in an animal model of infection: A feasibility pilot study

Abstract

Human β-defensin-3 (HBD-3) is an antimicrobial peptide with bactericidal effects on many gram-positive and gram-negative bacteria and some yeast species and, if radiolabeled, might be used to distinguish bacterial infection from sterile inflammation. The goals of the present study were to develop methods for radiolabeling HBD-3 with 99mTc and to perform preliminary investigations on 99mTc-labeled HBD-3 as a means to evaluate induced infection in an animal model. To this purpose, Staphylococcus aureus-induced infection was used to evaluate the capability of 99mTc-HBD-3 to distinguish infection from aseptic inflammation in rats. Methods: Twenty to 40 mg of recombinant HBD-3 were labeled with 99mTc+ hexa-coordinated with 3 molecules of CO and H 2O and separated by a column from free 99mTc. 99mTc-HBD-3 was added to cultures of a bacterial suspension of S. aureus and Escherichia coli to evaluate in vitro antibacterial activity. A bacterial suspension of S. aureus and a carrageenan solution were used to induce infection and sterile inflammation, respectively, in opposite thighs of 9 adult rats. Three separate experiments were performed on groups of 3 rats each. The animals received different doses of 99mTc-HBD-3 injected through a cannula into the jugular vein. After sacrifice of the animals, tissue samples were obtained from sites of infection, inflammation, and control muscle (left foreleg) at 1, 3, and 5 h after 99mTc-HBD-3 administration. Tissue samples were weighed and then counted in a well-counter. Simultaneously, 1 mL of a standard solution of 99mTc-HBD-3 corresponding to each administered dose was counted. Results: 99mTc-HBD-3 retained antibacterial activity. Radioactivity in tissue samples from the infected sites was significantly higher than that in samples of either induced inflammation or normal control muscle (ratio, ∼3:1) at 3 and 5 h after injection, whereas similar radioactivity counts were observed for tissue samples from aseptic inflammation sites and normal control muscle. Conclusion: In this investigation, 99mTc-HBD-3 retained antibacterial activity and successfully distinguished infection from aseptic inflammation in adult rats. Copyright © 2009 by the Society of Nuclear Medicine, Inc.